Absci (ABSI) Stock Forecast, Price Target & Predictions
ABSI Stock Forecast
Absci stock forecast is as follows: an average price target of $6.00 (represents a 135.29% upside from ABSI’s last price of $2.55) and a rating consensus of 'Buy', based on 4 wall street analysts offering a 1-year stock forecast.
ABSI Price Target
The average price target for Absci (ABSI) is $6.00 based on 1-year price targets from 4 Wall Street analysts in the past 3 months, with a price target range of $6.00 to $6.00. This represents a potential 135.29% upside from ABSI's last price of $2.55.
ABSI Analyst Ratings
According to 4 Wall Street analysts, Absci's rating consensus is 'Buy'. The analyst rating breakdown for ABSI stock is 0 'Strong Buy' (0.00%), 4 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Absci Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Mar 21, 2024 | Daniel Arias | Stifel Nicolaus | $6.00 | $5.28 | 13.64% | 135.29% |
The latest Absci stock forecast, released on Mar 21, 2024 by Daniel Arias from Stifel Nicolaus, set a price target of $6.00, which represents a 13.64% increase from the stock price at the time of the forecast ($5.28), and a 135.29% increase from ABSI last price ($2.55).
Absci Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 1 |
| Avg Price Target | - | - | $6.00 |
| Last Closing Price | $2.55 | $2.55 | $2.55 |
| Upside/Downside | -100.00% | -100.00% | 135.29% |
In the current month, the average price target of Absci stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Absci's last price of $2.55. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Oct 01, 2024 | Guggenheim | - | Buy | Initialise |
| Aug 15, 2024 | Cowen & Co. | Buy | Buy | Hold |
| Jul 03, 2024 | Morgan Stanley | - | Overweight | Initialise |
| Jun 28, 2024 | Cowen & Co. | Buy | Buy | Hold |
| May 15, 2024 | Truist Financial | Sector Outperform | Sector Outperform | Hold |
| Mar 22, 2024 | Scotiabank | Sector Outperform | Sector Outperform | Hold |
| Jan 08, 2024 | H.C. Wainwright | Buy | Buy | Hold |
| Aug 12, 2022 | Cowen & Co. | - | Outperform | Upgrade |
Absci's last stock rating was published by Guggenheim on Oct 01, 2024. The company Initialise its ABSI rating from "null" to "Buy".
Absci Financial Forecast
Absci Revenue Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | $744.00K | $3.37M | $1.27M | $1.56M | $2.37M | $1.00M | $819.00K | $1.45M | $1.54M | $728.00K |
| Avg Forecast | $8.50M | $12.95M | $6.65M | $6.55M | $1.76M | $1.75M | $1.91M | $2.10M | $900.00K | $3.00M | $2.44M | $2.25M | $4.73M | $1.87M | $1.62M | $1.79M | $1.69M | $2.01M | $1.75M |
| High Forecast | $10.64M | $16.21M | $8.32M | $8.20M | $2.41M | $2.19M | $1.91M | $2.63M | $1.18M | $3.75M | $3.05M | $2.81M | $5.92M | $1.87M | $1.62M | $1.79M | $1.69M | $2.01M | $1.75M |
| Low Forecast | $6.46M | $9.85M | $5.06M | $4.98M | $1.36M | $1.33M | $1.91M | $1.60M | $154.28K | $2.28M | $1.85M | $1.71M | $3.60M | $1.87M | $1.62M | $1.79M | $1.69M | $2.01M | $1.75M |
| # Analysts | 1 | 1 | 1 | 1 | 5 | 2 | 2 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 |
| Surprise % | - | - | - | - | - | - | - | - | - | 0.25% | 1.38% | 0.56% | 0.33% | 1.26% | 0.62% | 0.46% | 0.86% | 0.77% | 0.42% |
Absci's average Quarter revenue forecast for Dec 23 based on 4 analysts is $900.00K, with a low forecast of $154.28K, and a high forecast of $1.18M. ABSI's average Quarter revenue forecast represents a 20.97% increase compared to the company's last Quarter revenue of $744.00K (Sep 23).
Absci EBITDA Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 5 | 2 | 2 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 |
| EBITDA | - | - | - | - | - | - | - | - | - | $-18.74M | $-16.57M | $-19.52M | $-16.10M | $-23.89M | $-25.60M | $-25.77M | $-30.17M | $-22.35M | $-43.60M |
| Avg Forecast | $-8.50M | $-12.95M | $-6.65M | $-6.55M | $-1.76M | $-1.75M | $-1.91M | $-2.10M | $-900.00K | $-3.00M | $-2.44M | $-2.25M | $-4.73M | $-1.87M | $-1.62M | $-22.22M | $-1.69M | $-14.90M | $-1.75M |
| High Forecast | $-6.46M | $-9.85M | $-5.06M | $-4.98M | $-1.36M | $-1.33M | $-1.91M | $-1.60M | $-154.28K | $-2.28M | $-1.85M | $-1.71M | $-3.60M | $-1.87M | $-1.62M | $-17.77M | $-1.69M | $-11.92M | $-1.75M |
| Low Forecast | $-10.64M | $-16.21M | $-8.32M | $-8.20M | $-2.41M | $-2.19M | $-1.91M | $-2.63M | $-1.18M | $-3.75M | $-3.05M | $-2.81M | $-5.92M | $-1.87M | $-1.62M | $-26.66M | $-1.69M | $-17.88M | $-1.75M |
| Surprise % | - | - | - | - | - | - | - | - | - | 6.25% | 6.80% | 8.69% | 3.40% | 12.75% | 15.79% | 1.16% | 17.82% | 1.50% | 24.91% |
undefined analysts predict ABSI's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Absci's previous annual EBITDA (undefined) of $NaN.
Absci Net Income Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 5 | 2 | 2 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 |
| Net Income | - | - | - | - | - | - | - | - | - | $-21.99M | $-41.67M | $-23.36M | $-19.47M | $-27.26M | $-28.68M | $-29.49M | $-25.17M | $-23.63M | $-41.20M |
| Avg Forecast | $-16.47M | $-13.07M | $-16.47M | $-17.61M | $-24.28M | $-22.05M | $-20.61M | $-24.05M | $-24.14M | $-26.13M | $-27.04M | $-26.35M | $-28.58M | $-31.96M | $-35.25M | $-25.43M | $-27.89M | $-15.76M | $-19.36M |
| High Forecast | $-11.34M | $-8.99M | $-11.34M | $-12.12M | $-21.12M | $-15.18M | $-14.19M | $-16.56M | $-22.04M | $-17.99M | $-18.62M | $-18.14M | $-19.67M | $-31.96M | $-35.25M | $-20.34M | $-27.89M | $-12.60M | $-19.36M |
| Low Forecast | $-21.86M | $-17.34M | $-21.86M | $-23.37M | $-26.40M | $-29.26M | $-27.35M | $-31.91M | $-28.34M | $-34.67M | $-35.88M | $-34.97M | $-37.92M | $-31.96M | $-35.25M | $-30.51M | $-27.89M | $-18.91M | $-19.36M |
| Surprise % | - | - | - | - | - | - | - | - | - | 0.84% | 1.54% | 0.89% | 0.68% | 0.85% | 0.81% | 1.16% | 0.90% | 1.50% | 2.13% |
Absci's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. ABSI's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
Absci SG&A Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 5 | 2 | 2 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 |
| SG&A | - | - | - | - | - | - | - | - | - | $9.51M | $9.41M | $9.59M | $7.75M | $11.41M | $10.51M | $10.89M | $9.18M | $9.73M | $5.18M |
| Avg Forecast | $38.34M | $58.41M | $29.99M | $29.54M | $7.95M | $7.91M | $8.60M | $9.47M | $4.06M | $13.53M | $10.99M | $10.13M | $21.33M | $8.45M | $7.31M | $8.09M | $7.64M | $9.05M | $7.90M |
| High Forecast | $47.98M | $73.10M | $37.54M | $36.97M | $10.89M | $9.90M | $8.60M | $11.85M | $5.34M | $16.93M | $13.75M | $12.68M | $26.69M | $8.45M | $7.31M | $8.09M | $7.64M | $9.05M | $7.90M |
| Low Forecast | $29.15M | $44.41M | $22.81M | $22.46M | $6.14M | $6.01M | $8.60M | $7.20M | $695.89K | $10.29M | $8.35M | $7.71M | $16.22M | $8.45M | $7.31M | $8.09M | $7.64M | $9.05M | $7.90M |
| Surprise % | - | - | - | - | - | - | - | - | - | 0.70% | 0.86% | 0.95% | 0.36% | 1.35% | 1.44% | 1.35% | 1.20% | 1.08% | 0.66% |
Absci's average Quarter SG&A projection for Dec 23 is $4.06M, based on 4 Wall Street analysts, with a range of $695.89K to $5.34M. The forecast indicates a -57.29% fall compared to ABSI last annual SG&A of $9.51M (Sep 23).
Absci EPS Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 5 | 2 | 2 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 |
| EPS | - | - | - | - | - | - | - | - | - | $-0.24 | $-0.45 | $-0.26 | $-0.21 | $-0.30 | $-0.32 | $-0.33 | $-0.28 | $-0.33 | $-0.47 |
| Avg Forecast | $-0.14 | $-0.12 | $-0.14 | $-0.15 | $-0.21 | $-0.19 | $-0.18 | $-0.21 | $-0.21 | $-0.23 | $-0.24 | $-0.23 | $-0.25 | $-0.28 | $-0.31 | $-0.29 | $-0.25 | $-0.20 | $-0.17 |
| High Forecast | $-0.10 | $-0.08 | $-0.10 | $-0.11 | $-0.19 | $-0.13 | $-0.12 | $-0.15 | $-0.19 | $-0.16 | $-0.16 | $-0.16 | $-0.17 | $-0.28 | $-0.31 | $-0.29 | $-0.25 | $-0.20 | $-0.17 |
| Low Forecast | $-0.19 | $-0.15 | $-0.19 | $-0.21 | $-0.23 | $-0.26 | $-0.24 | $-0.28 | $-0.25 | $-0.31 | $-0.32 | $-0.31 | $-0.33 | $-0.28 | $-0.31 | $-0.29 | $-0.25 | $-0.20 | $-0.17 |
| Surprise % | - | - | - | - | - | - | - | - | - | 1.04% | 1.89% | 1.12% | 0.83% | 1.06% | 1.03% | 1.14% | 1.13% | 1.63% | 2.73% |
According to undefined Wall Street analysts, Absci's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to ABSI previous annual EPS of $NaN (undefined).
Absci Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| HEPA | Hepion Pharmaceuticals | $0.69 | $70.00 | 10044.93% | Buy |
| ELEV | Elevation Oncology | $0.61 | $9.00 | 1375.41% | Buy |
| XFOR | X4 Pharmaceuticals | $0.37 | $3.67 | 891.89% | Buy |
| INZY | Inozyme Pharma | $2.69 | $14.67 | 445.35% | Buy |
| RLAY | Relay Therapeutics | $4.64 | $19.40 | 318.10% | Buy |
| ZURA | Zura Bio | $2.93 | $10.00 | 241.30% | Buy |
| SANA | Sana Bio | $2.35 | $8.00 | 240.43% | Buy |
| ABOS | Acumen Pharmaceuticals | $2.31 | $7.00 | 203.03% | Buy |
| DAWN | Day One Biopharmaceuticals | $13.34 | $38.80 | 190.85% | Buy |
| AFMD | Affimed | $2.64 | $7.50 | 184.09% | Buy |
| DTIL | Precision BioSciences | $6.50 | $15.50 | 138.46% | Buy |
| ABSI | Absci | $2.55 | $6.00 | 135.29% | Buy |
| RXRX | Recursion Pharmaceuticals | $5.75 | $9.67 | 68.17% | Hold |
| CRBU | Caribou Biosciences | $1.98 | $3.00 | 51.52% | Buy |
| GRPH | LENZ Therapeutics | $3.18 | $4.00 | 25.79% | Hold |
| VECT | VectivBio | $16.87 | $18.00 | 6.70% | Buy |
| EXAI | Exscientia | $4.84 | $5.00 | 3.31% | Hold |